AbbVie Inc. Common Stock — Earnings

Past earnings

1. Wed · Apr 29EPS beat+3.1%on the day
   EPS $2.65 vs est $2.59Revenue $15.0B

   EPS of $2.65 beat the $2.59 estimate (+2%); revenue came in at $15.0B (+2% vs est). Shares rose 3.1% on the release day.

2. Wed · Feb 4EPS beat-3.8%on the day
   EPS $2.71 vs est $2.65Revenue $16.6B

   EPS of $2.71 beat the $2.65 estimate (+2%); revenue came in at $16.6B (+1% vs est). Shares fell 3.8% on the release day.

3. Fri · Oct 31EPS beat-4.5%on the day
   EPS $1.86 vs est $1.77Revenue $15.8B

   EPS of $1.86 beat the $1.77 estimate (+5%); revenue came in at $15.8B (+1% vs est). Shares fell 4.5% on the release day.

4. Thu · Jul 31EPS beat-0.2%on the day
   EPS $2.97 vs est $2.88Revenue $15.4B

   EPS of $2.97 beat the $2.88 estimate (+3%); revenue came in at $15.4B (+3% vs est). Shares fell 0.2% on the release day.

ABBV related news

• AbbVie Skyrizi Wins Pediatric Psoriatic Disease Label, Extending Post-Humira Runway (ABBV)Fri · Jun 26
• AbbVie (ABBV) Eyes $10.9B Biotech Buyout to Add Eczema Drug, Pressuring DupixentSat · Jun 20
• US Tariff Probe Into Germany Drug Pricing: What It Means for PFE, MRK, LLY Pharma StocksFri · Jun 19